Landmark Behavioral Health Study Presented at AHIP Event

July 07, 2021 at 08:00 AM EDT

Jonathan Mayhew, Ontrak CEO, and Dr. Hilary Placzek, Ontrak Senior Director Medical Economics and Outcomes, Featured In Most Recent AHIP Program: “How Deeper Engagements Drive Proven Outcomes”

Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI-powered and telehealth-enabled, virtualized healthcare company, today announced that over 200 healthcare decisionmakers and thought leaders registered with American Health Insurance Plans (“AHIP”) for the presentation of the landmark behavioral health study “Treatment Effect of the Ontrak Program” and a discussion of how the program engages high cost and complex populations with unaddressed behavioral health conditions and chronic disease, resulting in proven, durable outcomes and cost savings.

Mr. Mayhew noted in the presentation that Ontrak’s model of coaching to and through care, drives exceptionally high member engagement with the program even among those who have failed in other behavior change programs. Ontrak care coaches guide members to relevant clinical pathways and providers, and stay connected to each member throughout the 12-month Ontrak program, to ensure that social determinants of health are assessed and addressed with the same level of attention as behavioral health risks.

Dr. Placzek reported that the Treatment Effect study compared a cohort of Ontrak graduates to a propensity matched control group of the same size, and found that the Ontrak program delivers a statistically significant $486 per member per month cost savings, 64% reduction in avoidable inpatient utilization, and a 50% increase in use of preventive care services, durable 24 months post enrollment. During the webinar Dr. Placzek also explained how the impact of app-based digital health programs with short intervention periods tends to diminish over time, which reinforces foundational research on program durability. Durable behavior change requires longer term intervention.

In collaboration with advisors Robert M Kaplan and Jill Glassman PhD from the Stanford School of Medicine Clinical Excellence Research Center (CERC), Ontrak expects to submit the Treatment Effect study for peer review in August and publication in a leading medical journal.

To access a replay of the “How Deeper Engagements Drive Impactful, Proven Outcomes” presentation, please visit https://www.ontrak-inc.com/overcoming-barriers-to-behavioral-health-engagement.

About Ontrak, Inc.

Ontrak, Inc. (f/k/a Catasys, Inc.) is a leading AI and telehealth enabled, virtualized healthcare company, whose mission is to help improve the health and save the lives of as many people as possible. The company’s PRE™ (Predict-Recommend-Engage) platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages people who are not getting the care they need. By combining predictive analytics with human engagement, Ontrak delivers improved member health and validated outcomes and savings to healthcare payors.

The company’s integrated, technology-enabled Ontrak™ programs, a critical component of the PRE platform, are designed to provide healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions such as diabetes, hypertension, coronary artery disease, COPD, and congestive heart failure, which result in high medical costs. Ontrak has a unique ability to engage these members, who do not otherwise seek behavioral healthcare, leveraging proprietary enrollment capabilities built on deep insights into the drivers of care avoidance.

A landmark behavioral health study, “Treatment Effect of the Ontrak Program,” found that Ontrak’s program produces a statistically significant reduction of 64% in inpatient hospitalizations within the treatment group of individuals with untreated behavioral health needs and medical comorbidities. The program also resulted in an increase in utilization of preventative behavioral healthcare office visits. The savings for members who completed the 12-month program were statistically significant and notable at $486 per member per month, which equates to a savings of nearly $12,000 per member over two years, post enrollment. The cost for all-cause health office visits rose $110 per member per month, a positive change indicating uptake of productive, preventive care and fewer costly and avoidable inpatient hospitalizations. Advisors to the Ontrak research team led by Dr. Hilary Placzek include Robert M Kaplan, faculty member at the Stanford School of Medicine Clinical Excellence Research Center (CERC) and Jill Glassman PhD, Biostatistician and Senior Center Manager of Quantitative Analysis at the Stanford School of Medicine Clinical Excellence Research Center (CERC).

Ontrak integrates evidence-based psychosocial and medical interventions delivered either in-person or via telehealth, along with care coaching and in-market Community Care Coordinators who address the social and environmental determinants of health, including loneliness. The company’s programs improve member health and deliver validated cost savings to healthcare payors.

Learn more at www.ontrak-inc.com

Cautionary Note Regarding Forward-Looking Statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond our control, which may cause actual results to differ materially from stated expectations. These risk factors include, among others, changes in regulations or issuance of new regulations or interpretations, limited operating history, our inability to execute our business plan, increase our revenue and achieve profitability, lower than anticipated eligible members under our contracts, our inability to recognize revenue, lack of outcomes and statistically significant formal research studies, difficulty enrolling new members and maintaining existing members in our programs, the risk that treatment programs might not be effective, difficulty in developing, exploiting and protecting proprietary technologies, intense competition and substantial regulation in the health care industry, the risks associated with the adequacy of our existing cash resources and our ability to continue as a going concern, our ability to raise additional capital when needed and our liquidity. You are urged to consider statements that include the words "may," "will," "would," "could," "should," "believes," "estimates," "projects," "potential," "expects," "plan," "anticipates," "intends," "continues," "forecast," "designed," "goal," or the negative of those words or other comparable words to be uncertain and forward-looking. For a further list and description of the risks and uncertainties we face, please refer to our most recent Securities and Exchange Commission filings which are available on its website at http://www.sec.gov. Such forward-looking statements are current only as of the date they are made, and we assume no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210707005161/en/

Contacts

Investors:

Caroline Paul

Gilmartin Group

investors@ontrak-inc.com

About Us

Laser Focus World Membership

Magazine Subscription

Newsletter Subscription

The Daily Beam

Product Watch

Bio & Life Sciences Product Watch

Laser Processing Product Watch

Get Published!

Photonics Hot List

Following the Photons: A Photonics Podcast

Social Media

Meet the Laser Focus World Team

Editorial

Sales

Editorial Advisory Board

Landmark Behavioral Health Study Presented at AHIP Event

Contacts

More News